Advisability of switching of i.p. insulin in to CAPD.
D001786:Blood Glucose / Q000032:analysis; D003928:Diabetic Nephropathies / Q000188:drug therapy* / Q000628:therapy; D005500:Follow-Up Studies; D006442:Glycated Hemoglobin / Q000032:analysis; D006801:Humans; D007274:Injections, Intraperitoneal; D007279:Injections, Subcutaneous; D007328:Insulin / Q000008:administration & dosage*; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000379:methods; D018570:Risk Assessment
D001786:Blood Glucose; D006442:Glycated Hemoglobin; D007328:Insulin